Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Isacson

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Advances in Experimental Medicine and Biology|September 8, 2009
Molecular and cellular determinants for generating ES-cell derived dopamine neurons for cell therapyJan Pruszak, Ole Isacson
Journal of Neurochemistry|August 12, 2010
The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndromeHyemyung Seo, Ole Isacson
Science Translational Medicine|February 21, 2012
Viral and inflammatory triggers of neurodegenerative diseasesMichela Deleidi, Ole Isacson
Annals of Neurology|January 8, 2009
Future of cell and gene therapies for Parkinson's diseaseOle Isacson, Jeffrey H Kordower
Human Molecular Genetics|July 22, 2008
Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patientsHyemyung Seo, Woori Kim, Ole Isacson
The FEBS Journal|September 27, 2022
Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementiasOliver Cooper, Penny Hallett, Ole Isacson
Molecular and Cellular Neurosciences|March 2, 2005
Netrin-1 and slit-2 regulate and direct neurite growth of ventral midbrain dopaminergic neuronsLing Lin, Yi Rao, Ole Isacson
Parkinsonism & Related Disorders|December 15, 2011
Using stem cells and iPS cells to discover new treatments for Parkinson's diseaseOliver Cooper, Penny Hallett, Ole Isacson
Progress in Brain Research|December 1, 2012
Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapyOliver Cooper, Malin Parmar, Ole Isacson
Neurobiology of Disease|November 9, 2017
Increased motor neuron resilience by small molecule compounds that regulate IGF-II expressionTeresia M Osborn, Jonathan Beagan, Ole Isacson
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Advances in Experimental Medicine and Biology|September 8, 2009
Molecular and cellular determinants for generating ES-cell derived dopamine neurons for cell therapyJan Pruszak, Ole Isacson
Journal of Neurochemistry|August 12, 2010
The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndromeHyemyung Seo, Ole Isacson
Science Translational Medicine|February 21, 2012
Viral and inflammatory triggers of neurodegenerative diseasesMichela Deleidi, Ole Isacson
Annals of Neurology|January 8, 2009
Future of cell and gene therapies for Parkinson's diseaseOle Isacson, Jeffrey H Kordower
Human Molecular Genetics|July 22, 2008
Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patientsHyemyung Seo, Woori Kim, Ole Isacson
The FEBS Journal|September 27, 2022
Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementiasOliver Cooper, Penny Hallett, Ole Isacson
Molecular and Cellular Neurosciences|March 2, 2005
Netrin-1 and slit-2 regulate and direct neurite growth of ventral midbrain dopaminergic neuronsLing Lin, Yi Rao, Ole Isacson
Parkinsonism & Related Disorders|December 15, 2011
Using stem cells and iPS cells to discover new treatments for Parkinson's diseaseOliver Cooper, Penny Hallett, Ole Isacson
Progress in Brain Research|December 1, 2012
Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapyOliver Cooper, Malin Parmar, Ole Isacson
Neurobiology of Disease|November 9, 2017
Increased motor neuron resilience by small molecule compounds that regulate IGF-II expressionTeresia M Osborn, Jonathan Beagan, Ole Isacson
Pageof 14